CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
GLYCANC investigates the role of proteoglycans and glycosaminoglycans in cancer progression. The project aims to understand their dysregulation and potential as targets for multitargeted cancer therapies through advanced structural analysis and molecular studies.
Cancer is a leading cause of mortality within the aging European population.
Therapeutic targeting is hampered by the complexity of the disease, which includes not only molecular changes within the tumor cell itself, but also within its microenvironment.
Tumor angiogenesis, tumor-stroma interactions, interactions with immune cells, with the extracellular matrix and cancer stem cell niches allow for malignant cell survival and promote metastasis, the leading cause for cancer-associated mortality.…
UNIVERSITAET MUENSTER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Reims
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Varese
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Greece, Rio Patras
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Sweden, Uppsala
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
